StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3077% above fair value
$56.63+0.23 (+0.41%)

Close on Nov 19, 2026Market cap $5.07BP/E 40.7Yield –

Liquidia net income

Net income is the profit left for shareholders after every expense, interest and tax.

Liquidia's net income for the twelve months ending Jun 30, 2026 was $138.61M. For fiscal 2025 it was -$68.92M. The highest annual figure on record is -$34.58M in fiscal 2021.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$68.92M–
FY2024Dec 31, 2024-$128.29M–
FY2023Dec 31, 2023-$78.50M–
FY2022Dec 31, 2022-$41.02M–
FY2021Dec 31, 2021-$34.58M–
FY2020Dec 31, 2020-$59.76M–
FY2019Dec 31, 2019-$47.58M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$74.72M–
Q1 FY2026Mar 31, 2026$52.86M–
Q4 FY2025Dec 31, 2025$14.56M–
Q3 FY2025Sep 30, 2025-$3.53M–
Q2 FY2025Jun 30, 2025-$41.58M–
Q1 FY2025Mar 31, 2025-$38.37M–
Q4 FY2024Dec 31, 2024-$38.51M–
Q3 FY2024Sep 30, 2024-$31.03M–
Q2 FY2024Jun 30, 2024-$28.67M–
Q1 FY2024Mar 31, 2024-$30.08M–
Q4 FY2023Dec 31, 2023-$27.45M–
Q3 FY2023Sep 30, 2023-$15.79M–
Q2 FY2023Jun 30, 2023-$23.52M–
Q1 FY2023Mar 31, 2023-$11.75M–
Q4 FY2022Dec 31, 2022-$6.53M–
Q3 FY2022Sep 30, 2022-$9.09M–
Q2 FY2022Jun 30, 2022-$9.45M–
Q1 FY2022Mar 31, 2022-$15.94M–
Q4 FY2021Dec 31, 2021-$11.56M–
Q3 FY2021Sep 30, 2021-$7.28M–
Q2 FY2021Jun 30, 2021-$6.55M–
Q1 FY2021Mar 31, 2021-$9.18M–
Q4 FY2020Dec 31, 2020-$16.09M–
Q3 FY2020Sep 30, 2020-$14.97M–
Q2 FY2020Jun 30, 2020-$13.92M–
Q1 FY2020Mar 31, 2020-$14.79M–

More Liquidia figures

See a number that looks wrong?